Truist raised the firm’s price target on Procter & Gamble to $160 from $155 but keeps a Hold rating on the shares. The firm is updating its model after the company’s recent Q2 earnings beat, the analyst tells investors in a research note. Truist adds that Procter & Gamble is operating at one of the strongest levels in the 20 years of covering the name, but also believes there are “limited catalysts” for the company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PG:
- Procter & Gamble Issues $1.35B in Public Offering Notes
- Procter & Gamble price target raised to $165 from $155 at Bernstein
- Procter & Gamble price target raised to $165 from $160 at Barclays
- Procter & Gamble Company Is Worried About This – Should You Be Worried Too?
- Procter & Gamble price target raised to $157 from $156 at RBC Capital
